Latest Financial Performance News

Aeeris Ltd reported solid growth in Q2 FY25, driven by increased annual recurring revenue and new contracts across key sectors, while unveiling a promising new technology set to expand its market footprint.

ImpediMed Limited has reported record quarterly revenue and cash receipts for Q2 FY25, alongside significant growth in reimbursement coverage and a robust sales pipeline, signaling strong momentum in its digital health platform business.

BirdDog Technology reports a strategic pivot with four next-generation product launches, a 20% price increase, and a robust cash position, despite a 13% revenue decline in H1 FY25.

ResMed Inc. posted a robust second quarter for fiscal year 2025, with revenue climbing 10% to $1.3 billion and operating profit soaring 52%, driven by strong demand for sleep and breathing health products and operational efficiencies.

Donaco International posted modest revenue and EBITDA gains in Q2 FY2025, alongside a stronger cash position, while navigating regulatory uncertainties in Southeast Asia.

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.

WhiteHawk Limited reports solid Q4 2024 results with $718K revenue and a major $2.4 million contract renewal, while advancing new partnerships and managing costs amid a modest operational cash loss.

EVZ Limited reported a robust $3.2 million net positive operating cash inflow in Q2 FY25, bolstered by new contract wins worth approximately $28 million and a healthy $110 million contract backlog.

EVE Health Group has completed the sale of its Robyndale tea tree property and relaunched its postbiotic concentrate range, signaling a strategic shift towards innovation and growth in the Australian market.

Galena Mining Limited reports a challenging December quarter at its 60%-owned Abra Base Metals Mine, marked by production declines and ongoing voluntary administration. The company appoints a new CEO for Abra and explores recapitalisation options to stabilise operations.

MFF Capital Investments Limited has announced a fully franked ordinary dividend of AUD 0.08 per share, payable in May 2025, alongside shareholder-friendly reinvestment and bonus security plans.

MFF Capital Investments Limited has reported a striking net profit after tax of $381.5 million for the half year ended December 31, 2024, more than doubling last year’s result. The company also announced an increased fully franked interim dividend of 8 cents per share, underscoring its robust financial position and growth trajectory.